McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid salesMcKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.
Supreme Court Blocks Nationwide Opioid SettlementThe Supreme Court rejected a multi-billion dollar settlement with Purdue Pharma, allowing lawsuits affecting the opioid crisis to continue.
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over OxyContinPurdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits related to the opioid crisis.
McKinsey to pay $650m to settle US opioid consulting probeMcKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.
McKinsey to Pay $650 Million in Opioid Settlement With Justice DepartmentMcKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.
Ex-McKinsey partner pleads guilty to destroying records on opioidsA former McKinsey partner pleaded guilty to obstructing justice in relation to Purdue Pharma's opioid sales strategy.
McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid salesMcKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.
Supreme Court Blocks Nationwide Opioid SettlementThe Supreme Court rejected a multi-billion dollar settlement with Purdue Pharma, allowing lawsuits affecting the opioid crisis to continue.
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over OxyContinPurdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits related to the opioid crisis.
McKinsey to pay $650m to settle US opioid consulting probeMcKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.
McKinsey to Pay $650 Million in Opioid Settlement With Justice DepartmentMcKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.
Ex-McKinsey partner pleads guilty to destroying records on opioidsA former McKinsey partner pleaded guilty to obstructing justice in relation to Purdue Pharma's opioid sales strategy.
Federal Circuit Affirms Invalidity of Purdue's OxyContin PatentsThe Federal Circuit affirmed the invalidity of Purdue Pharma's OxyContin patents due to obviousness, impacting patent law standards.The ruling highlights the importance of analyzing inherent properties and known problems in patent obviousness evaluations.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue PharmaThe Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.
McKinsey & Company to pay $650 million for role in opioid crisisMcKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.
The Supreme Court Rejects a Nationwide Opioid Settlement With OxyContin Maker Purdue PharmaThe Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue PharmaThe Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.
McKinsey & Company to pay $650 million for role in opioid crisisMcKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.
The Supreme Court Rejects a Nationwide Opioid Settlement With OxyContin Maker Purdue PharmaThe Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.
Money for California's Opioid Fight in Limbo After US Supreme Court Ruling | KQEDNegotiations in Purdue Pharma case could potentially lead to bankruptcy for Sackler family, impacting how funds will be distributed among plaintiffs.
Purdue Opioid Settlement on Verge of Collapse After Supreme Court RulingThe Supreme Court rejected liability protections for Purdue Pharma's owners, jeopardizing the settlement and release of funds crucial for combating opioid addiction.
Supreme Court Rejects Liability Shield at Center of Purdue Pharma SettlementThe Supreme Court rejected a provision shielding the Sackler family in the Purdue Pharma settlement, impacting the distribution of funds to address the opioid epidemic.
U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo | CBC NewsThe U.S. Supreme Court rejected a nationwide settlement with Purdue Pharma, blocking the shield for the Sackler family and billions to combat opioids.
Supreme Court Rejects Liability Shield at Center of Purdue Pharma SettlementThe Supreme Court rejected a provision shielding the Sackler family in the Purdue Pharma settlement, impacting the distribution of funds to address the opioid epidemic.
U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo | CBC NewsThe U.S. Supreme Court rejected a nationwide settlement with Purdue Pharma, blocking the shield for the Sackler family and billions to combat opioids.